|
Effects of three-dimensional conformal radiotherapy and image-guided radiotherapy on patients with liver cancer
|
F. Xu   , P. Xu |
| Department of Radiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei Province, China , ki2233@163.com |
|
|
Abstract: (33 Views) |
Background: This study focuses on analyzing the effects of three-dimensional conformal radiotherapy (3DCRT) and image-guided radiotherapy (IGRT) on the safety and prognosis of individuals with hepatocellular carcinoma (HCC). Materials and Methods: Eighty cases of HCC individuals admitted between January 2023 and December 2023 were studied; the control group received IGRT intervention with 34 cases; the research group received 3DCRT intervention with 46 cases. The safety (incidence of grade 1, 2, and 3 hepatic toxic side effects), prognosis, range of lower extremity computed tomography angiography-planned target volume (CTV-PTV) externally, and efficacy of the treatment were comparatively analyzed. Results: The data manifested that the incidence of grade 1 toxicity in the research group exceeded that in the control group, but the incidence of grade 3 toxicity in the research group was lower, and the 1-year and 2-year survival rates in the research group were greater. The median survival time in the research group was longer than that in the control group. The range of CTV-PTV exposure in the left and right, head and foot, anterior and posterior aspects was lower than that in the control group. In addition, the CR+PR rate was significantly higher in the research group. Conclusion: These outcomes revealed that IGRT is more suitable for HCC patients than 3DCRT, which not only has a certain degree of safety, but also can help to significantly improve the prognosis. |
|
| Keywords: Hepatocellular carcinoma, image-guided radiotherapy, three-dimensional conformal radiotherapy, safety, prognosis. |
|
|
Full-Text [PDF 761 kb]
(10 Downloads)
|
|
Type of Study: Original Research |
Subject:
Radiation Biology
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
